RATIONALE: Dopamine (DA) modulates working memory. However, the relation between DA systems and episodic (declarative) memory is less established. Frontal lobe DA function may be involved. We were interested in assessing whether apomorphine (Apo), a drug used extensively in clinical research as a probe of DA function, has an effect on episodic memory test performance in healthy volunteers. OBJECTIVE: To investigate the effect of a presynaptic dose of Apo on episodic memory tests and on other tests thought to be sensitive to frontal lobe functions. METHODS:Twenty healthy subjects were treated with Apo HCl (5 microg/kg sc) or placebo (10 subjects/group) in a randomized, double blind parallel group design and performance on a battery of cognitive tests was assessed. RESULTS:Apomorphine significantly impaired performance on tests of source recognition (d.f.=19, p=0.05) and item recognition memory (d.f.=19, p<0.05), and memory interference (d.f.=19, p<0.010). No significant change was found on other tests (Go/no-Go Test, Categorized Words, Stroop, Trail Making Test, and verbal fluency). CONCLUSION: Findings in this small sample of subjects suggest that dopaminergic transmission affects episodic memory functions.
RCT Entities:
RATIONALE: Dopamine (DA) modulates working memory. However, the relation between DA systems and episodic (declarative) memory is less established. Frontal lobe DA function may be involved. We were interested in assessing whether apomorphine (Apo), a drug used extensively in clinical research as a probe of DA function, has an effect on episodic memory test performance in healthy volunteers. OBJECTIVE: To investigate the effect of a presynaptic dose of Apo on episodic memory tests and on other tests thought to be sensitive to frontal lobe functions. METHODS: Twenty healthy subjects were treated with Apo HCl (5 microg/kg sc) or placebo (10 subjects/group) in a randomized, double blind parallel group design and performance on a battery of cognitive tests was assessed. RESULTS:Apomorphine significantly impaired performance on tests of source recognition (d.f.=19, p=0.05) and item recognition memory (d.f.=19, p<0.05), and memory interference (d.f.=19, p<0.010). No significant change was found on other tests (Go/no-Go Test, Categorized Words, Stroop, Trail Making Test, and verbal fluency). CONCLUSION: Findings in this small sample of subjects suggest that dopaminergic transmission affects episodic memory functions.
Authors: Paul Allen; Christopher A Chaddock; Oliver D Howes; Alice Egerton; Marc L Seal; Paolo Fusar-Poli; Isabel Valli; Fern Day; Philip K McGuire Journal: Schizophr Bull Date: 2011-05-02 Impact factor: 9.306
Authors: Luca Passamonti; Maria Salsone; Nicola Toschi; Antonio Cerasa; Marco Giannelli; Carmelina Chiriaco; Giuseppe Lucio Cascini; Francesco Fera; Aldo Quattrone Journal: Brain Behav Date: 2013-03-22 Impact factor: 2.708
Authors: Regina V Guarnieri; Rafaela L Ribeiro; Altay A Lino de Souza; José Carlos F Galduróz; Luciene Covolan; Orlando F A Bueno Journal: Front Psychiatry Date: 2016-03-18 Impact factor: 4.157
Authors: Shane M Fresnoza; Giorgi Batsikadze; Lynn Elena Müller; Constanze Rost; Michael Chamoun; Walter Paulus; Min-Fang Kuo; Michael A Nitsche Journal: Pharmaceutics Date: 2021-05-13 Impact factor: 6.321